Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist designed to bind to GLP-1 receptors, which help regulate appetite.[4] Semaglutide was originally developed as a treatment for T2D to improve blood sugar levels, but clinical trials later showed that patients also lost weight while taking it.[4-8] Additional studies support semaglutides effectiveness in promoting weight loss in non-diabetics.[5,8,11] Semaglutide supports weight loss by suppressing appetite, delaying stomach emptying, and stimulating insulin secretion.[4] It is typically used alongside dietary changes and exercise in adults with and without diabetes.[4] All GLP-1 medications require a prescription from a healthcare provider
N Engl J Med 393:2636 Wharton S, Freitas P, Hjelmesth J et al (2025) 1966-LB: efficacy and safety of semaglutide 7.2 mg in ObesitySTEP UP trial
Our approach eliminates the necessity to visit a clinic physically, maintaining focus on impactful results for you, wherever you are in California
Monitoring caloric intake becomes critical
Through advanced training in the EvexiPEL Method, EVEXIAS Health Solutions delivers the clinical expertise and strategic support providers need to improve patient outcomes and build stronger practices
For a detailed clinical comparison of these two drugs, read our Mounjaro vs Ozempic guide